• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过多因素人工智能分析预测新冠病毒疾病的严重程度及发病情况

Severity-onset prediction of COVID-19 via artificial-intelligence analysis of multivariate factors.

作者信息

Fu Yu, Zeng Lijiao, Huang Pilai, Liao Mingfeng, Li Jialu, Zhang Mingxia, Shi Qinlang, Xia Zhaohua, Ning Xinzhong, Mo Jiu, Zhou Ziyuan, Li Zigang, Yuan Jing, Wang Lifei, He Qing, Wu Qikang, Liu Lei, Liao Yuhui, Qiao Kun

机构信息

Department of Infectious Diseases, Department of Thoracic Surgery, Department of Radiology, National Clinical Research Center for Infectious Disease, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen Third People's Hospital, Shenzhen, China.

Department of Biostatistics, HuaJia Biomedical Intelligence, Shenzhen, China.

出版信息

Heliyon. 2023 Jul 27;9(8):e18764. doi: 10.1016/j.heliyon.2023.e18764. eCollection 2023 Aug.

DOI:10.1016/j.heliyon.2023.e18764
PMID:37576285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10415884/
Abstract

Progression to a severe condition remains a major risk factor for the COVID-19 mortality. Robust models that predict the onset of severe COVID-19 are urgently required to support sensitive decisions regarding patients and their treatments. In this study, we developed a multivariate survival model based on early-stage CT images and other physiological indicators and biomarkers using artificial-intelligence analysis to assess the risk of severe COVID-19 onset. We retrospectively enrolled 338 adult patients admitted to a hospital in China (severity rate, 31.9%; mortality rate, 0.9%). The physiological and pathological characteristics of the patients with severe and non-severe outcomes were compared. Age, body mass index, fever symptoms upon admission, coexisting hypertension, and diabetes were the risk factors for severe progression. Compared with the non-severe group, the severe group demonstrated abnormalities in biomarkers indicating organ function, inflammatory responses, blood oxygen, and coagulation function at an early stage. In addition, by integrating the intuitive CT images, the multivariable survival model showed significantly improved performance in predicting the onset of severe disease (mean time-dependent area under the curve = 0.880). Multivariate survival models based on early-stage CT images and other physiological indicators and biomarkers have shown high potential for predicting the onset of severe COVID-19.

摘要

病情进展为重症仍然是新冠病毒疾病(COVID-19)死亡的主要风险因素。迫切需要可靠的模型来预测重症COVID-19的发病,以支持针对患者及其治疗的敏感决策。在本研究中,我们基于早期CT图像以及其他生理指标和生物标志物,利用人工智能分析开发了一个多变量生存模型,以评估重症COVID-19发病的风险。我们回顾性纳入了中国一家医院收治的338例成年患者(重症率为31.9%;死亡率为0.9%)。比较了重症和非重症患者的生理和病理特征。年龄、体重指数、入院时的发热症状、并存的高血压和糖尿病是重症进展的风险因素。与非重症组相比,重症组在早期显示出提示器官功能、炎症反应、血氧和凝血功能的生物标志物异常。此外,通过整合直观的CT图像,多变量生存模型在预测重症疾病发病方面表现出显著改善的性能(平均时间依赖性曲线下面积=0.880)。基于早期CT图像以及其他生理指标和生物标志物的多变量生存模型在预测重症COVID-19发病方面显示出很高的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/481dc62fdb31/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/a8567c45eb93/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/d936ecad8c35/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/cc7bc472de60/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/4eb4b3f96c47/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/481dc62fdb31/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/a8567c45eb93/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/d936ecad8c35/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/cc7bc472de60/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/4eb4b3f96c47/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7fc/10415884/481dc62fdb31/gr5.jpg

相似文献

1
Severity-onset prediction of COVID-19 via artificial-intelligence analysis of multivariate factors.通过多因素人工智能分析预测新冠病毒疾病的严重程度及发病情况
Heliyon. 2023 Jul 27;9(8):e18764. doi: 10.1016/j.heliyon.2023.e18764. eCollection 2023 Aug.
2
Prediction and Feature Importance Analysis for Severity of COVID-19 in South Korea Using Artificial Intelligence: Model Development and Validation.利用人工智能预测和分析韩国 COVID-19 严重程度及特征重要性:模型建立与验证。
J Med Internet Res. 2021 Apr 19;23(4):e27060. doi: 10.2196/27060.
3
The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.血细胞计数作为预测 COVID-19 疾病进展的潜在生物标志物:一项回顾性研究。
Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115. doi: 10.1515/cclm-2020-0377.
4
Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.人工智能基于过度的单核细胞激活、过度的器官损伤和炎症综合征与 COVID-19 严重程度的相关性预测 COVID-19 严重程度:一项前瞻性临床研究。
Front Immunol. 2021 Aug 27;12:715072. doi: 10.3389/fimmu.2021.715072. eCollection 2021.
5
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.基于初始纤维蛋白原与白蛋白比值和血小板计数分析预测 COVID-19 重症。
Platelets. 2020 Jul 3;31(5):674-679. doi: 10.1080/09537104.2020.1760230. Epub 2020 May 5.
6
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.利用 C 反应蛋白与白蛋白比值对重症 COVID-19 患者的疾病进展进行早期预测。
Dis Markers. 2021 Dec 3;2021:6304189. doi: 10.1155/2021/6304189. eCollection 2021.
7
The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.SOFA 评分在 COVID-19 患者中的预后价值:一项回顾性、观察性研究。
Medicine (Baltimore). 2021 Aug 13;100(32):e26900. doi: 10.1097/MD.0000000000026900.
8
Prognostication of patients with COVID-19 using artificial intelligence based on chest x-rays and clinical data: a retrospective study.基于胸部 X 光片和临床数据的人工智能预测 COVID-19 患者的预后:一项回顾性研究。
Lancet Digit Health. 2021 May;3(5):e286-e294. doi: 10.1016/S2589-7500(21)00039-X. Epub 2021 Mar 24.
9
Prediction of mortality in COVID-19 through combing CT severity score with NEWS, qSOFA, or peripheral perfusion index.通过将 CT 严重程度评分与 NEWS、qSOFA 或外周灌注指数相结合预测 COVID-19 患者的死亡率。
Am J Emerg Med. 2021 Dec;50:546-552. doi: 10.1016/j.ajem.2021.08.079. Epub 2021 Sep 2.
10
[Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].[新型冠状病毒肺炎重型/危重型患者临床特征分析及预警模型构建]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):401-406. doi: 10.3760/cma.j.cn121430-20200325-00410.

引用本文的文献

1
Prediction models based on machine learning algorithms for COVID-19 severity risk.基于机器学习算法的新型冠状病毒肺炎严重程度风险预测模型。
BMC Public Health. 2025 May 13;25(1):1748. doi: 10.1186/s12889-025-22976-x.
2
Association between Vaccination Status for COVID-19 and the Risk of Severe Symptoms during the Endemic Phase of the Disease.2019冠状病毒病疫苗接种状况与疾病流行阶段严重症状风险之间的关联
Vaccines (Basel). 2023 Sep 22;11(10):1512. doi: 10.3390/vaccines11101512.

本文引用的文献

1
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
2
Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan.年龄对 COVID-19 疫苗和医疗负担对 COVID-19 死亡的影响,日本东京。
Emerg Infect Dis. 2022 Sep;28(9):1777-1784. doi: 10.3201/eid2809.220377. Epub 2022 Jul 12.
3
COVID-19 Symptoms and Deaths among Healthcare Workers, United States.
医护人员中的 COVID-19 症状和死亡,美国。
Emerg Infect Dis. 2022 Aug;28(8):1624-1641. doi: 10.3201/eid2808.212200. Epub 2022 Jul 7.
4
Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial.COVID-19 住院成人清醒俯卧位评估:一项非随机对照试验。
JAMA Intern Med. 2022 Jun 1;182(6):612-621. doi: 10.1001/jamainternmed.2022.1070.
5
The Spectrum of Biochemical Alterations with Molecular and Serological Biomarkers in the Diagnosis of COVID-19: Searching for Novel One to Identify Disease Earlier with Better Prognosis and Drug Discovery.新型冠状病毒肺炎生化指标及分子血清标志物谱:寻找新型标志物以更早识别疾病并改善预后及药物研发。
Recent Adv Antiinfect Drug Discov. 2021;16(3):179-181. doi: 10.2174/2772434416666211122112743.
6
Risk Factors for COVID-19 in Patients with Hypertension.高血压患者感染新型冠状病毒肺炎的风险因素
Can J Infect Dis Med Microbiol. 2021 May 7;2021:5515941. doi: 10.1155/2021/5515941. eCollection 2021.
7
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic and SARS-CoV-2.采用地方性病毒和 SARS-CoV-2 病毒提取物的多重血清抗体筛查平台。
ACS Infect Dis. 2021 Jun 11;7(6):1596-1606. doi: 10.1021/acsinfecdis.0c00725. Epub 2021 Mar 16.
8
Recent Insights into Emerging Coronavirus: SARS-CoV-2.新兴冠状病毒的最新研究进展:SARS-CoV-2。
ACS Infect Dis. 2021 Jun 11;7(6):1369-1388. doi: 10.1021/acsinfecdis.0c00646. Epub 2020 Dec 9.
9
Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19.新型血清学生物标志物可预测 COVID-19 患者的疾病严重程度
Int Immunopharmacol. 2020 Dec;89(Pt A):107065. doi: 10.1016/j.intimp.2020.107065. Epub 2020 Oct 3.
10
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.利用 ISARIC WHO 临床特征协议对因 COVID-19 住院的患者进行风险分层:4C 死亡率评分的制定和验证。
BMJ. 2020 Sep 9;370:m3339. doi: 10.1136/bmj.m3339.